Opendata, web and dolomites

DIABETESMART

The first Clinically Validated AI-powered Diabetes Assistant

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 DIABETESMART project word cloud

Explore the words cloud of the DIABETESMART project. It provides you a very rough idea of what is the project "DIABETESMART" about.

least    context    10b    artificial    clinical    children    daily    benefit    28       pioneer    patient    foresee    forecast    clinically    stat    mobile    12    75    recommendations    physician    18m    life    integrate    2015    medical    insights    intelligent    415    fatal    revenues    shown    prevalence    provides    81    sugar    2021    cagr    2045    2022    iia    thousand    europes    validated    platform    642    country    live    chronic    mdr    estimate    blood    self    million    diagnosed    disease    complications    employees    time    potentially    easier    19    start    mellitus    market    mission    66    profits    hedia    normal    cumulative    diabetesmart    phone    company    powered    founded    device    200    individuals    2026    class    improvement    2017    outperforms    26    2040    obtain    diabetes    compliant    lifestyle    11    28b    people    corporates    137    globally    health    ai    glucose    bellow    25    2016    care    69    danish    team    app    wearable   

Project "DIABETESMART" data sheet

The following table provides information about the project.

Coordinator
HEDIA IVS 

Organization address
address: OLE MAALOES VEJ 3
city: KOBENHAVN
postcode: 2200
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Denmark [DK]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-05-01   to  2019-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    HEDIA IVS DK (KOBENHAVN) coordinator 50˙000.00

Map

 Project objective

Diabetes mellitus, a common chronic disease that is associated with high blood glucose (also called blood sugar) can lead to potentially fatal health complications. Globally, 415 million people were diagnosed with diabetes in 2015, estimated to reach 642 million by 2040. In Europe disease prevalence is high, 66 million people were diagnosed in 2017, estimate to reach 81 million people by 2045, with 28,200 children (bellow 19 years old) diagnosed each year. Diabetes requires long-life care management from a physician care team and patient daily self-management. Improvement of diabetes self-care was shown when people with diabetes used mobile phone application. Yet, the challenge is to identify a clinical relevant App between the thousand diabetes management applications available in the market. Hedia, a Danish pioneer start-up company was founded with the mission to make life easier for people with diabetes. Based on the current challenges, we have developed a mobile platform for the daily diabetes management that outperforms the current stat-of-the-art: clinically validated Class IIA compliant to Europes’s new MDR; an artificial intelligent powered that provides tailored recommendations based on the individuals lifestyle and country context; integrate the user’s blood medical device and wearable of choice and other advanced features that enable people with diabetes live a normal life. DIABETESMART project targets the diabetes care market, which has an estimate value of €69.10B in 2016, forecast to reach €137.28B by 2022 with a 12.4% CAGR (2016-2022). We aim to offer DIABETESMART to corporates -who will obtain further revenues of €18M per year- and to people with diabetes who will benefit from real-time clinically meaningful insights based on AI by 2021. We foresee to reach revenues of €26.6 million with €75.1 million in cumulative profits and increase our team to at least 25 employees (from current 11) by 2026.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "DIABETESMART" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "DIABETESMART" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More  

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

BeatsDigTherapeutics (2019)

Project SCALE: Tailored Digital Therapeutics for Neurological and Brain Disorders

Read More